Elevated maternal mid-trimester chorionic gonadotropin ≥4 MoM is associated with fetal cerebral blood flow redistribution

References

• Spencer K. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome. Prenat Diagn 2000; 20: 652–6.
   Google Scholar
• Haddad B, Abirached F, Louis-Sylvestre C, Le Blond J, Paniel BJ, Zorn JR. Predictive value of early human chorionic gonadotrophin serum profiles for fetal growth retardation. Hum Reprod 1999; 14: 2872–5.
   Google Scholar
• Muller F, Aegerter P, Boue A. Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and neonatal death. Prenat Diag 1993; 13: 29–43.
   Google Scholar
• Luckas M, Hawe J, Meekins J, Neilson J, Walkinshaw S. Second trimester serum free beta human chorionic gonadotropin levels as a predictor of pre-eclampsia. Acta Obstet Gynecol Scand 1998; 77: 381–4.
   Google Scholar
• Walton DL, Norem CT, Schoen EJ, Ray GT, Colby CJ. Second-trimester serum chorionic gonadotropin concentrations and complications and outcome of pregnancy. N Engl J Med 1999; 341: 2033–8.
   Google Scholar
• Miyakoshi K, Tanaka M, Gabionza D, Ishimoto H, Miyazaki T, Yoshimura Y. Prediction of smallness for gestational age by maternal serum human chorionic gonadotropin levels and by uterine artery Doppler study. Fetal Diagn Ther 2001; 16: 42–6.
   Google Scholar
• Palacio M, Jauniaux E, Kingdom J, Dell E, Shedrake A, Rodeck CH. Perinatal outcome in pregnancies with a positive serum screening for Down’s syndrome due to elevated levels of free beta-human chorionic gonadotropin. Ultrasound Obstet Gynecol 1999; 13: 58–62.
   Google Scholar
• Mari G, Deter RL. Middle cerebral artery flow velocity waveforms in abnormal and small for gestational age fetuses. Am J Obster Gynecol 1992; 166: 1262–70.
   Google Scholar
• Trudinger BJ, Cook CM, Giles WB, Ng S, Fong E, Connelly A et al. Fetal umbilical artery velocity waveforms and subsequent neonatal outcome. Br J Obstet Gynaecol 1991; 98: 378–84.
   Google Scholar
• Isler CM, Barrilleaux PS, Rinehart BK, Magann EF, Martin JN. Postpartum magnesium sulfate prophylaxis: a prospective trial utilizing clinical parameters toindicate duration of therapy for hypertensive diseases of pregnancy. Obstet Gynecol 2001; 97: S44.
   Google Scholar
• Sterne G, Shields LE, Dubinski TJ. Abnormal fetal cerebral and umbilical Doppler measurements in fetuses with intrauterine growth restriction predicts the severity of perinatal morbidity. J Clin Ultrasound 2001; 29: 146–51.
   Google Scholar
• Gramellini D, Piantelli G, Verrotti C, Fieni S, Chiaie LD, Kaihura C. Doppler velocimetry and non stress test in severe fetal growth restriction. Clin Exp Obstet Gynecol 2001; 28: 33–9.
   Google Scholar
• Herskovitz R, Kingdom JC, Geary M, Rodeck CH. Fetalcerebral blood flow redistribution in late gestation: identification of compromise in small fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol 2000; 15: 209–12.
   Google Scholar
• Fong KW, Ohlsson A, Hannah ME, Grisau S, Kingdom J, Cohen H et al. Prediction of perinatal outcome in fetuses suspected to have intrauterine growth restriction: Doppler US study of fetal cerebral, renal, and umbilical arteries. Radiology 1999; 213: 681–9.
   Google Scholar
• Ozeren M, Dinc H, Ekmen U, Senekayli C, Aydemir V Umbilical and middle cerebral artery Doppler indices in patients with preeclampsia. Eur J Obstet Gynecol Reprod Biol 1999; 82: 11–6.
   Google Scholar
• Hershkovitz R, Furman B, Bashiri M, Hallak M, Sheiner E, Smolin A et al. Evidence for abnormal middle cerebral aetery in patients with idiopathic hydramnios. J Maternal Fetal Med 2001; 10: 414–19.
   Google Scholar
• Chen WH, Lai HC, Tang YH, Liu HS. Fetal Doppler hemodynamics changes in spontaneous versus prostaglandin E1-induced active labor. Acta Obstet Gynecol Scand 1999; 78: 599–604.
   Google Scholar
• Fejgin MD, Kedar I, Amiel A, Ben-Tovim T, Che R, Petel Y et al. Elevated hCG as an isolated finding during the second trimester biochemical screen: genetic, ultrasonic, and perinatal significance. Prenat Diag 1997; 17: 1027–31.
   Google Scholar
• Wax JR, Lopes AM, Benn PA, Lerer T, Steinfeld JD, Indardia CJ. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome. J Matern Fetal Med 2000; 9: 161–4.
   Google Scholar
• Morssink LP, Heringa MP, Bekhius JR, De Wolf BTHM, Mantingh A. The HELLP syndrome. its association with unexplained elevation of MSAFP and MShCG in the second trimester. Prenat Diagn 1997; 17: 601–6.
   Google Scholar
• Yaron Y, Cherry M, Kramer RL, O’Brien JE, Hallak M, Johnson MP et al. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, betahuman chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol 1999; 181: 968–74.
   Google Scholar
• Lieppman RE, Williams MA, Cheng EY, Resta R, Zingheim R, Hic Luthy DA. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. Am J Obstet Gynecol 1993; 168: 1852–6.
   Google Scholar
• Morssink LP, Herringa MP, Beekhius JR, de Wolf BT, Mantingh A. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein. Obstet Gynecol 1997; 89: 666–70.
   Google Scholar
• Morssink LP, Kornman LH, Beekhius JR, de Wolf BT, Mantingh A. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery. Prenat Diagn 1995; 15: 1041–6.
   Google Scholar
• Tanaka M, Natori M, Kohno H, Ishimoto H, Kobayashi T, Nozawa S. Fetal growth in patients with elevated maternal serum hCG levels. Obstet Gynecol 1993; 81: 341–3.
   Google Scholar
• Luckas MJ, Sandland R, Hawe J, Neilson JP, McFadyen IR, Meekins JW. Fetal growth retardation and second trimester maternal serum human chorionic gonadotropin levels. Placenta 1998; 19: 143–7.
   Google Scholar
• Lockwood CJ, Kuczynski E. Markers of risk for preterm delivery. J Perinat Med 1999; 27: 5–20. Review.
   Google Scholar
• Onderoglu LS, Kabukcu A. Elevated second trimester human chorionic gonadotropin is associated with adverse pregnancy outcome. Int J Gynaecol Obstet 1997; 56: 245–9.
   Google Scholar
• Lee LC, Sheu BC, Shau WY, Liu DM, Lai TJ, Huang SC. Mid-trimester beta-hCG levels incorporated in a multifactorial model for the prediction of severe pre-eclampsia. Prenat Diagn 2000; 20: 738–43.
   Google Scholar
• Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA. Can antenatal and biochemical markers predict the development of severe preeclampsia? Am J Obstet Gynecol 2000; 182: 589–94.
   Google Scholar
• Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 1992; 80: 83–6.
   Google Scholar
• Jauniaux E, Gulbis B, Tunkel S, Ramsay B, Campbell S, Meuris S. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies. Prenat Diagn 1996; 16: 1129–35.
   Google Scholar
• Raty R, Kokinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP, and free ß-hCG levels. Prenat Diagn 1999; 19: 122–7.
   Google Scholar
• Fraser RF 2nd, McAsey ME, Coney P. Inhibin-A and proalpha C are elevated in preeclamptic pregnancy and correlate with human chorionic gonadotropin. Am J Reprod Immunol 1998; 40: 37–42.
   Google Scholar
• Lidqvist P, Grennert L, Marsal K. Epidermal growth factor in maternal urine – a predictor of intrauterine growth restriction? Early Hum Dev 1999; 56: 143–50.
   Google Scholar
• Myatt L, Miodovnik M. Prediction of preeclampsia (Review). Semin Perinatol 1999; 23: 45–57.
   Google Scholar
• Pouta AM, Hartikainen AL, Vuolteenaho OJ, Ruokonen AO, Laatikainen TJ. Midtrimester N-terminal proatrial natriuretic peptide, free beta hCG, and alpha-fetoprotein in predicting preeclampsia. Obstet Gynecol 1998; 91: 940–4.
   Google Scholar
• Marviel P, Muller F, Guibourdenche J, Berkane N, Gaudet R, Breart G et al. Correlations between serum assays of human chorionic gonadotrophin (hCG) andhuman placental lactogen (hPL) and pre-eclampsia or intrauterine growth restriction IUGR) among nulliparas younger than 38 years. Eur J Obstet Gynecol Reprod Biol 2001; 95: 59–67.
   Google Scholar
• Yaron Y, Jaffa AJ, Har-Toov J, Lavi H, Legum C, Evans MI. Doppler velocimetry of the umbilical artery as a predictor of outcome in pregnancies characterized by elevated beta-subunit human chorionic gonadotropin. Fetal Diagn Ther 1997; 12: 353–5.
   Google Scholar
• Fong KW Ohlsson A, Hannah ME, Grisau S, Kingdom J, Cohen H et al. Prediction of perinatal outcome in fetuses suspected to have intrauterine growth restriction: Doppler US study of fetal cerebral, renal, and umbilical arteries. Radiology 1999; 213: 681–9.
   Google Scholar